CPMS | NEWSLETTER | ERN
HealthFlex
×
  • Home
  • The Network
    • Who We Are
    • Our Vision, Mission & Aim
    • Structure & Governance
    • Specialised Centres
    • Coordinators
    • Stakeholders & Supporters
    • Informative Materials
  • For Patients
    • Patient Board
    • Find a specialist centre
    • Patient Organisations
    • Patient Resources
    • Cross-border Healthcare
  • For Professionals
    • Education Programme
    • Evaluation
    • Guidelines
    • UIMD Registry
    • Subnetworks
    • Work Packages
    • Transversal Activities
    • CPMS Support
    • Resources
  • Activities
    • Projects
    • Publications
  • News & Events
    • News
    • Events
  • Education Programme
    • My Courses
    • Login
  • Contact Us

“Genetic therapies” course in Heidelberg – 22-24 June

“Genetic therapies” course in Heidelberg – 22-24 June
Education for ProfessionalsEventsNews

Registration is now open for the “Genetic therapies” course promoted by Recordati Rare Disease Fondation d’Entreprise, which will be held in person from 22 to 24 June 2023, in Heidelberg (Germany).

The course will provide valuable insights into the rapidly evolving field of genetic therapies and their application in rare diseases, mainly inherited metabolic diseases. It will explore how new technologies are being used and how they can change medical practice in the future. In addition, some challenges associated with the development of genetic therapies, such as safety, long-term efficacy, sustainability, pricing, and access to innovative medications will be discussed.

Specifically, the learning objectives of the course will be:

      • to understand the principles of the techniques used for replacing, modulating and altering genetic information in order to cure disease or attenuate the clinical phenotype
      • to learn about current strategies used to deliver nucleic acids to different organs and compartments within the body
      • to explore the clinical development of genetic therapies, particularly the identification of meaningful endpoints, and the determination of dosing regimens
      • to define the challenges in providing access to high-priced medications for rare diseases and to look at alternative pricing models
      • to learn about the patient’s perspectives, expectations and concerns about genetic therapies.

This can also represent an opportunity for healthcare professionals and stakeholders to stay up-to-date with the latest advances in the field, network with other professionals, and better understand the opportunities and challenges in developing and implementing genetic therapies in rare diseases.

The course is open to healthcare professionals and scientists with interest in genetic therapies, as well as professionals from the pharmaceutical industry and regulatory bodies involved in the development and licensing of these therapies.

Online registration is required by the 5th of May 2023.

To see the detailed programme of the course and to have any further information about registration, fees and logistics, please visit the course website.

Search

Last News & Events

  • DCTEP learners’ stories: How does an e-learning on IMDs really look like?
  • Conference on Rare diseases and European reference networks in Bilbao
  • Swedish SLOS Conference – October 2, 2023
  • Brain Metabolism Workshop – 6-7 July 2023
  • “Genetic therapies” course in Heidelberg – 22-24 June
  • Liver Transplant for Inborn Errors of Metabolism – Sharing Knowledge Across ERNs
  • 6th World Conference on CDG – 21-23 July 2023
  • Gyrate Atrophy of the Choroid and Retina – International hybrid symposium

Activities

  • Publications and Guidelines
  • Unified Registry for Inherited Metabolic Disorders
  • Projects

Disclaimer

MetabERN is a European Reference Network (ERN) approved by the ERN Board of Member States.
The ERNs are co-funded by the European Commission.
For more information about the ERNs and the EU health strategy, please visit ec.europa.eu/health/ern
The content on this website represents the views of the network and is its sole responsibility; it can in no way be taken to reflect the views of the European Commission or any other body of the European Union.

For more information please contact
Prof. Maurizio Scarpa, MD, PhD
MetabERN Coordinator

Newsletter

Sign up to the MetabERN newsletter

Search the website


Copyright ©2017-2021 all rights reserved
Previous Content

Web by EFFIGE 2.0
To provide the best possible service, we use technical, statistical and third-party cookies on this site. Continuing the navigation you consent to use them. Accept Reject Read More
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT